With a now committed owner and a truly global marketing and sales organization, demand for the Mirena family of intra-uterine devices grew rapidly. Sales are up ten-fold under Bayer’s ownership. By the end of 2015, Mirena sales reached the one billion euro run-rate. This milestone earns Turku’s Mirena “blockbuster” status – and, in that respect, a notable first for Finland.
Read the whole story at www.healthfinland.fi